News
December 13, 2024

IU announces $138 million Lilly Endowment grant, launches partnership to accelerate bioscience innovation

Regenstrief one of the partners expected to drive advancements and commercialization in biosciences 

Regenstrief Institute will partner with Indiana University and other key bioscience organizations in the state to make significant advances in human health and help make Indiana a global leader in bioscience innovation by establishing the IU Launch Accelerator for Biosciences, known as IU LAB, at the 16 Tech Innovation District in Indianapolis. 

“IU LAB will play a critical role in advancing life and biosciences innovation to address our state’s most critical health challenges,” said Rachel Patzer, PhD, MPH, Regenstrief president and CEO. Through its efforts to translate research into practice, this partnership will lead to better health outcomes and improved health care across Indiana.”  

View the complete press release on Indiana University’s webpage 

Partners

Related News

Medications for Alcohol Use Disorder reduce healthcare spending

Medications for Alcohol Use Disorder reduce healthcare spending

Alcohol Use Disorder (AUD) remains a major public health challenge in the United States, contributing to more than 170,000

Low Cancer Screening Rates Among Emergency Department Patients: A Multicenter Retrospective Study.

Published in the journal Cancer investment. Here is a link to the article.  Regenstrief Institute author: Paul I. Musey, M.D., M.S.  The content below

Susan Hickman and Kathleen Unroe lead expansion of advance care planning program

Leadership stability, peer support essential when implementing care programs in nursing homes

Despite a pressing need to improve outcomes and address inequities in nursing homes, there is limited evidence about the

Reimagining real-world health data as essential public infrastructure

Reimagining real-world health data as essential public infrastructure

Researchers propose standards and community oversight to improve interoperability, accountability and public trust The U.S. healthcare system runs on